Turning Point
Sienna's great grandmother, grandmother and grandfather all developed breast cancer. Dana-Farber physicicans are assessing the genetic risk for her mother.
Winter/Spring 2004
Contents
- Assessing cancer risk
Genetic testing in cancer-prone families - From 'medieval' to modern
Gentler biopsies lead advances in breast cancer diagnosis - Quality of life
Psychotherapy eases emotional anxiety - A gift of time
New drugs extend survival in advanced disease - Stalking a stealthy disease
Hunting early warning signals in ovarian cancer - Tailored treatments
In breast cancer, distinctions make the difference - Women's Cancers Program: the first 10 years
A message from DFCI President Edward J. Benz Jr., MD
Credits
Turning Point is published for supporters of Dana-Farber's Women's Cancers Program. To learn more about the WCP, call Candace S. Lowe, ScD, administrative director, at (617) 632-2675. Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Turning Point
Dana-Farber Cancer Institute
Department of Communications
375 Longwood Avenue
Boston, MA 02215-5347
or call (617) 632-4090
Editor Dawn Stapleton
Associate Editor Richard Saltus
Art Director John DiGianni
Design Caroline Kraunelis
Production Coordinator Kristin Lacey
Contributors Christine Cleary, Elizabeth Gehrman, Robert Levy
Photography Eric Antoniou, Dan Furness, Shawn Henry, Matt McKee, Mark Ostow, Brian Smith
